...
首页> 外文期刊>Japanese journal of clinical oncology. >Does tumor size or microvascular invasion affect prognosis in patients with renal cell carcinoma?
【24h】

Does tumor size or microvascular invasion affect prognosis in patients with renal cell carcinoma?

机译:肿瘤大小或微血管侵犯是否会影响肾细胞癌患者的预后?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: We retrospectively evaluated the effects of tumor size and microvascular tumor invasion on the clinical outcomes of patients who had undergone radical nephrectomy for renal cell carcinoma (RCC). METHODS: One-hundred and sixty-two patients who received radical nephrectomy for localized or locally invasive RCC from 1989 to 2002 were included. We evaluated a new cut-off value for tumor size by dividing patients into groups by tumor diameter from 3.0 to 7.0 cm in 1.0 cm increments and compared the prognosis with that predicted by the 2002 TNM classification. We also re-classified localized microvascular tumor invasion as invasive disease. RESULTS: Univariate analyses showed a 5.0 cm cut-off provided the greatest difference in recurrence (p = 0.004) and survival (p = 0.001). Microvascular invasion made no significant difference in tumor recurrence and tumor-specific survival. However, in the new categories used in this study, survival in the locally invasive group was poor compared with the localized group. CONCLUSION: Our study showed that a tumor diameter of 5.0 cm might be the critical size to determine the prognosis of patients with localized RCC. Microvascular invasion seemed to have the necessity of re-evaluation in the TNM classification for patients with RCC.
机译:背景:我们回顾性评估了肿瘤大小和微血管肿瘤浸润对接受肾癌根治术的患者临床结局的影响。方法:纳入1989年至2002年因局部或局部浸润性RCC接受根治性肾切除术的162例患者。我们通过按3.0到7.0 cm的肿瘤直径(以1.0 cm的增量)将患者分组,评估了肿瘤大小的新临界值,并将预后与2002 TNM分类预测的预后进行了比较。我们还将局部微血管肿瘤浸润重新分类为浸润性疾病。结果:单因素分析显示,5.0 cm的切除率在复发率(p = 0.004)和生存率(p = 0.001)方面提供了最大的差异。微血管浸润在肿瘤复发和肿瘤特异性生存方面无显着差异。但是,在本研究中使用的新类别中,与局部治疗组相比,局部浸润组的生存期较差。结论:我们的研究表明,直径为5.0 cm的肿瘤可能是确定局部RCC患者预后的关键尺寸。对于RCC患者,微血管浸润似乎需要对TNM分类进行重新评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号